Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiation-Enhanced DLI for Relapsed Hematologic Malignancy
NCT00984165Phase 2Terminated
- Sponsor
- National Cancer Institute
- Start
- Jan 2010
- Primary completion
- Jan 2013
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of donor lymphocyte infusion in hematologic malignancy, Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL), chronic lymphocytic leukemia (CLL), multiple myeloma (MM), sponsored by National Cancer Institute. Started Jan 2010; status: terminated.
02
Drugs
donor lymphocyte infusion
03
Conditions
hematologic malignancyHodgkin lymphoma (HL)non-Hodgkin lymphoma (NHL)chronic lymphocytic leukemia (CLL)multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00984165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00984165.